All Work

David Moadel

Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat

Citigroup just slapped a Sell rating on one of 2026's most explosive biotech stocks, warning that soaring investor hopes around a cancer vaccine partnership with Merck have carried the valuation into dangerous territory.

David Moadel · 3 weeks ago